OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy
Fang Wang, Ran Li, Linlin Zhao, et al.
European Journal of Pharmacology (2020) Vol. 885, pp. 173387-173387
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives
Jasvinder Singh Bhatti, Abhishek Sehrawat, Jayapriya Mishra, et al.
Free Radical Biology and Medicine (2022) Vol. 184, pp. 114-134
Open Access | Times Cited: 358

Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
Qi Jin, Tong‐Tong Liu, Yuan Qiao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 125

A natural products solution to diabetic nephropathy therapy
Qichao Hu, Lan Jiang, Qi Yan, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108314-108314
Closed Access | Times Cited: 71

Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies
M. A. Darenskaya, С. И. Колесников, Н. В. Семенова, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12378-12378
Open Access | Times Cited: 45

Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction
Simeng Liu, Yanggang Yuan, Yi Xue, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 41

Resveratrol from Dietary Supplement to a Drug Candidate: An Assessment of Potential
Shivani Khattar, Sauban Ahmed Khan, Syed Amir Azam Zaidi, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 957-957
Open Access | Times Cited: 39

Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective
Mehrdad Hashemi, Mohammad Arad Zandieh, Setayesh Ziaolhagh, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 5, pp. 166714-166714
Open Access | Times Cited: 32

Recent Advances in Health Benefits of Stilbenoids
Yen‐Chun Koh, Chi‐Tang Ho, Min‐Hsiung Pan
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 35, pp. 10036-10057
Closed Access | Times Cited: 46

Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies
Hengchang Hu, Yuanhong Lei, Weihua Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35

Polyphenols and Their Metabolites in Renal Diseases: An Overview
Íris Guerreiro, Cíntia Ferreira‐Pêgo, Diogo Carregosa, et al.
Foods (2022) Vol. 11, Iss. 7, pp. 1060-1060
Open Access | Times Cited: 31

Biochanin A Ameliorates Nephropathy in High-Fat Diet/Streptozotocin-Induced Diabetic Rats: Effects on NF-kB/NLRP3 Axis, Pyroptosis, and Fibrosis
Chetan Ram, Shobhit Gairola, Shobhit Verma, et al.
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1052-1052
Open Access | Times Cited: 17

Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway
Wei Gu, Xing Wang, Huanfen Zhao, et al.
European Journal of Pharmacology (2022) Vol. 918, pp. 174776-174776
Closed Access | Times Cited: 26

Mitochondrial Oxidative Stress and Cell Death in Podocytopathies
Yuting Zhu, Cheng Wan, Jihong Lin, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 403-403
Open Access | Times Cited: 26

Diosgenin Targets CaMKK2 to Alleviate Type II Diabetic Nephropathy through Improving Autophagy, Mitophagy and Mitochondrial Dynamics
Yujie Zhong, Ruyi Jin, Ruilin Luo, et al.
Nutrients (2023) Vol. 15, Iss. 16, pp. 3554-3554
Open Access | Times Cited: 13

Resveratrol reduces RVLM neuron activity via activating the AMPK/Sirt3 pathway in stress-induced hypertension
Linping Wang, Tian‐Feng Liu, Tengteng Dai, et al.
Journal of Biological Chemistry (2025), pp. 108394-108394
Open Access

Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling
Marziyeh Salami, Raziyeh Salami, Alireza Mafi, et al.
Current Molecular Pharmacology (2021) Vol. 15, Iss. 5, pp. 716-735
Closed Access | Times Cited: 25

Insulin resistance in glomerular podocytes: Potential mechanisms of induction
Dorota Rogacka
Archives of Biochemistry and Biophysics (2021) Vol. 710, pp. 109005-109005
Closed Access | Times Cited: 23

Grifola frondosa Polysaccharide Ameliorates Early Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway
Tao Jiang, Sile Shen, Liang Wang, et al.
Applied Biochemistry and Biotechnology (2022) Vol. 194, Iss. 9, pp. 4093-4104
Closed Access | Times Cited: 15

Molecular Mechanistic Pathways Targeted by Natural Compounds in the Prevention and Treatment of Diabetic Kidney Disease
Kaixuan Zhou, Zi Xue, Jiayu Song, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6221-6221
Open Access | Times Cited: 15

Sirtuins as novel pharmacological targets in podocyte injury and related glomerular diseases
Tong‐Tong Liu, Liping Yang, Huimin Mao, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113620-113620
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top